MRs having difficulties in meeting with doctors, bringing huge negative impacts on sales

Beginning this January, the ‘Financial Gain & Expenditure Report’ has started to bring impacts in the industry.

Unlike the expectation that the industry would start to adapt to the enforcement after confusion only in the beginning because it was a policy implemented for the first time, it has shown a strength to suffocate sales power of pharmaceutical companies.

One of the biggest causes is d...